Your browser doesn't support javascript.
loading
Orexins and fear: implications for the treatment of anxiety disorders.
Flores, África; Saravia, Rocío; Maldonado, Rafael; Berrendero, Fernando.
Afiliación
  • Flores Á; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Saravia R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Maldonado R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain. Electronic address: rafael.maldonado@upf.edu.
  • Berrendero F; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain. Electronic address: fernando.berrendero@upf.edu.
Trends Neurosci ; 38(9): 550-9, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26216377
ABSTRACT
An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Miedo / Orexinas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Trends Neurosci Año: 2015 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Miedo / Orexinas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Trends Neurosci Año: 2015 Tipo del documento: Article País de afiliación: España